Pharmaceutical Executive

Pharmaceutical Executive-03-01-2009
Volume: 0
Issue: 0
Pharmaceutical Executive-03-17-2009
Volume: 0
Issue: 0
Pharmaceutical Executive-03-03-2009
Volume: 0
Issue: 0
Pharmaceutical Executive-03-25-2009
Volume: 0
Issue: 0
Pharmaceutical Executive-03-12-2009
Volume: 0
Issue: 0
Pharmaceutical Executive-03-19-2009
Volume: 0
Issue: 0
Pharmaceutical Executive-03-11-2009
Volume: 0
Issue: 0
Pharmaceutical Executive-03-24-2009
Volume: 0
Issue: 0
Pharmaceutical Executive-02-03-2009
Volume: 0
Issue: 0
Pharmaceutical Executive-02-10-2009
Volume: 0
Issue: 0
Pharmaceutical Executive-02-24-2009
Volume: 0
Issue: 0
Pharmaceutical Executive-02-26-2009
Volume: 0
Issue: 0
Pharmaceutical Executive-02-19-2009
Volume: 0
Issue: 0
Pharmaceutical Executive-02-12-2009
Volume: 0
Issue: 0

Pharmaceutical Executive-02-01-2009
Volume: 0
Issue: 0
Pharmaceutical Executive-02-17-2009
Volume: 0
Issue: 0
Pharmaceutical Executive-02-05-2009
Volume: 0
Issue: 0
Pharmaceutical Executive-01-15-2009
Volume: 0
Issue: 0
Pharmaceutical Executive-01-08-2009
Volume: 0
Issue: 0

Pharmaceutical Executive-01-01-2009
Volume: 0
Issue: 0
Pharmaceutical Executive-01-22-2009
Volume: 0
Issue: 0
Pharmaceutical Executive-01-20-2009
Volume: 0
Issue: 0
Pharmaceutical Executive-01-27-2009
Volume: 0
Issue: 0
Pharmaceutical Executive-01-13-2009
Volume: 0
Issue: 0
Pharmaceutical Executive-01-29-2009
Volume: 0
Issue: 0

Pharmaceutical Executive-12-01-2008
Volume: 0
Issue: 0
Pharmaceutical Executive-12-17-2008
Volume: 0
Issue: 0
Pharmaceutical Executive-12-10-2008
Volume: 0
Issue: 0
Pharmaceutical Executive-12-03-2008
Volume: 0
Issue: 0

Pharmaceutical Executive-12-01-2008
Volume: 0
Issue: 0
Advertisement
Advertisement
Trending on PharmExec
1
Beyond Amyloid, Part One (of two): Tau and Microglia Redefine the Alzheimer’s Pipeline
2
What the Peptide Advisory Vote Actually Means: Q&A with James LaValle
3
Hanmi Pharm Enters $2.3 Billion Licensing Agreement with Genentech for HM17321
4
Focusing on Asset Acquisition Over Building a Single Platform Technology
5
